التفاصيل البيبلوغرافية
| العنوان: |
The impact of remission and coexisting migraine on anxiety and depression in cluster headache. |
| المؤلفون: |
Kim, Byung-Su, Chung, Pil-Wook, Kim, Byung-Kun, Lee, Mi Ji, Park, Jeong Wook, Chu, Min Kyung, Ahn, Jin-Young, Bae, Dae Woong, Song, Tae-Jin, Sohn, Jong-Hee, Oh, Kyungmi, Kim, Daeyoung, Kim, Jae-Moon, Kim, Soo-Kyoung, Choi, Yun-Ju, Chung, Jae Myun, Moon, Heui-Soo, Chung, Chin-Sang, Park, Kwang-Yeol, Cho, Soo-Jin |
| المصدر: |
Journal of Headache & Pain; 5/29/2020, Vol. 21 Issue 1, p1-10, 10p |
| مصطلحات موضوعية: |
ANXIETY diagnosis, DIAGNOSIS of mental depression, MENTAL depression risk factors, AGE distribution, ANXIETY, CLUSTER headache, COMPARATIVE studies, CONFIDENCE intervals, LONGITUDINAL method, MEDICAL cooperation, MIGRAINE, MULTIVARIATE analysis, QUESTIONNAIRES, RESEARCH, RISK assessment, SEX distribution, COMORBIDITY, DISEASE remission, DISEASE prevalence, SEVERITY of illness index, ODDS ratio, SYMPTOMS |
| مستخلص: |
Background: Our aim was to investigate the relationship between coexisting cluster headache (CH) and migraine with anxiety and depression during active cluster bouts, and how symptoms change during remission. Methods: We analyzed data from 222 consecutive CH patients and 99 age- and sex-matched controls using a prospective multicenter registry. Anxiety or depression was evaluated using the Generalized Anxiety Disorder-7 (GAD-7) or Patient Health Questionnaire-9 (PHQ-9), respectively. Moderate-to-severe anxiety or depression was defined as a score of ≥10 at baseline (during a cluster bout). We assessed for changes in anxiety and depression during CH remission periods. Results: Among the CH patients, the prevalence of moderate-to-severe anxiety and depression was seen in 38.2% and 34.6%, respectively. Compared with controls, CH patients were associated with moderate-to-severe anxiety and depression (multivariable-adjusted odds ratio [aOR] = 7.32, 95% confidence intervals [CI] = 3.35–15.99 and aOR = 4.95, 95% CI = 2.32–10.57, respectively). CH patients with migraine were significantly more likely to have moderate-to-severe anxiety and depression (aOR = 32.53, 95% CI = 6.63–159.64 and aOR = 16.88, 95% CI = 4.16–68.38, respectively), compared to controls without migraine. The GAD-7 and PHQ-9 scores were significantly reduced between cluster bout and remission periods (from 6.8 ± 5.6 to 1.6 ± 2.8; P < 0.001, and from 6.1 ± 5.0 to 1.8 ± 2.4; P < 0.001, respectively). Conclusions: Our results indicate that CH patients are at increased risk of anxiety and depression, especially in the presence of coexisting migraine. However, the anxiety and depression can improve during remission periods. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Headache & Pain is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder